As announced in connection with the simplified tender offer initiated by Seqens, PCAS has decided to increase its share capital by a total of €200 million (including share premium) at the simplified tender offer price (i.e. €8 per share).

This capital increase follows the squeeze-out of PCAS shares on December 8, 2023.

The completion of this capital increase, fully subscribed by Seqens, the company's sole shareholder, was recorded by the Board of Directors at its meeting today.

This capital increase significantly strengthens PCAS's shareholders' equity and reduces its indebtedness in the same proportions.

PCAS's sole shareholder also decided today to transform PCAS into a simplified joint stock company.

Copyright (c) 2023 CercleFinance.com. All rights reserved.